🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, single-arm, open-label, multicenter clinical study aime...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-10-01
Trial ID
NCT07182708
Treatments Being Tested
Global, Phase 3, randomized, multicenter, open-label study evaluating the e...
Status
Recruiting
Location
St. Jude Medical Center
Start Date
2025-12-17
Trial ID
NCT07185997
Treatments Being Tested
An Open-label, Single-arm, Phase II Clinical Study of Firmonertinib in Peri...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-30
Trial ID
NCT07622706
This is a Phase 3, global, double-blind, randomized, controlled multicenter...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-05-28
Trial ID
NCT07010419
Treatments Being Tested
This study is a Phase III, international, multicenter, randomized, controll...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-09-26
Trial ID
NCT06970639
This is an open-label phase 2 study to evaluate the safety, tolerability an...
Status
Recruiting
Location
Hanhui Cancer Hospital
Start Date
2024-11-25
Trial ID
NCT06668103
Treatments Being Tested
This is a phase II study aimed to assess the efficacy and safety of firmone...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03
Trial ID
NCT06890182
Treatments Being Tested
This study evaluates the efficacy and safety of Firmonertinib 160 mg once d...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07298148
Treatments Being Tested
Primary Objective: To evaluate the efficacy of high-dose firmonertinib com...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-15
Trial ID
NCT06971406
Treatments Being Tested
This study is a randomized, open, multicenter phase III clinical study, whi...
Status
Recruiting
Location
Ethics Committee of cancer hospital, Chinese Academy of Medical Sciences
Start Date
2024-11-19
Trial ID
NCT06956001